Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 6376 AL 6390

Polyamines signalling pathway: A key player in unveiling the molecular mechanisms underlying Huntington's disease

Shiwal A, Nibrad D, Tadas M, Katariya R, Kale M, Wankhede N, Kotagale N, Umekar M, Taksande B.

Neuroscience. 2025 Mar 27;570:213-224. doi: 10.1016/j.neuroscience.2025.02.042. Epub 2025 Feb 20.

Structural insights into substrate transport and drug inhibition of the human vesicular monoamine transporter 2 (VMAT2)

Wu D, Zhao Y, Jiang D.

FEBS J. 2025 Sep;292(18):4789-4796. doi: 10.1111/febs.70003. Epub 2025 Jan 30.

Unveiling Multiple Sclerosis: Acute Hemichorea Masquerading as Sydenham's Chorea

Saibaba J, Karuppiah G, Nayak AR, Subrahmanyam D.

J Assoc Physicians India. 2025 Jan;73(1):e29-e30. doi: 10.59556/japi.73.0807.

Impact of Particulate Matter 2.5 on Neurological Diseases: Insights Into Pathophysiological and Molecular Mechanisms

Rubio C, López-Landa A, Serrano-García N, Romo-Parra H, Rubio-Osornio M.

J Toxicol. 2025 Dec 30;2025:5752904. doi: 10.1155/jt/5752904. eCollection 2025.

Chorea and seizures in a patient with a rare VPS13A gene mutation and neuroacanthocytosis

Srinivasan VA, Moorthy J, Kamalasekar K, Rajendran B.

BMJ Case Rep. 2025 Oct 17;18(10):e266167. doi: 10.1136/bcr-2025-266167.

The potential of machine learning to personalized medicine in Neurogenetics: Current trends and future directions

Ghorbian M, Ghorbian S.

Comput Biol Med. 2025 Sep;196(Pt A):110756. doi: 10.1016/j.compbiomed.2025.110756. Epub 2025 Jul 10.

Mechanistic correlation of potassium channel sensing and nitric oxide activity in neuroinflammation

Mannan A, Singh TG.

Mol Biol Rep. 2025 Sep 8;52(1):874. doi: 10.1007/s11033-025-10954-w.

Clinical insights into catechin-based nanomedicine: a review of therapeutic potential in neurodegenerative diseases

Al Amin M, Zehravi M, Sweilam SH, Shanmugarajan TS, Arjun UVNV, Nagaiyan MB, Reddy SM, Subash V, Swarnalatha KM, Pazhanikumar A, Mart J, Prasad PD, Khan MI, Ahmad I, Emran TB.

3 Biotech. 2025 Sep;15(9):294. doi: 10.1007/s13205-025-04470-8. Epub 2025 Aug 13.

Acute and reversible dyskinesias secondary to lithium toxicity: case report and literature review

Falletti M, Di Flumeri F, Zampogna A, Patera M, Fabbrini G, Suppa A.

BMC Neurol. 2025 Sep 29;25(1):393. doi: 10.1186/s12883-025-04419-7.

Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology

Dhariwal R, Jain M, Mir YR, Singh A, Jain B, Kumar P, Tariq M, Verma D, Deshmukh K, Yadav VK, Malik T.

Front Med (Lausanne). 2025 Jan 29;12:1522223. doi: 10.3389/fmed.2025.1522223. eCollection 2025.

Targeting signaling pathways in neurodegenerative diseases: Quercetin's cellular and molecular mechanisms for neuroprotection

Islam MR, Al-Imran MIK, Zehravi M, Sweilam SH, Mortuza MR, Gupta JK, Shanmugarajan TS, Devi K, Tummala T, Alshehri MA, Rajagopal K, Asiri M, Ahmad I, Emran TB.

Animal Model Exp Med. 2025 May;8(5):798-818. doi: 10.1002/ame2.12551. Epub 2025 Jan 22.

Role of Thrombosis in Neurodegenerative Diseases: An Intricate Mechanism of Neurovascular Complications

Beura SK, Panigrahi AR, Yadav P, Kulkarni PP, Lakhanpal V, Singh B, Singh SK.

Mol Neurobiol. 2025 Apr;62(4):4802-4836. doi: 10.1007/s12035-024-04589-4. Epub 2024 Nov 1.

Huntington's Disease-Like 2 in a European Caucasian Patient

Rodrigues CC, Antunes AP, Oliveira J, Freixo JP, Guedes LC, Carvalho V.

Mov Disord Clin Pract. 2025 Oct;12(10):1653-1655. doi: 10.1002/mdc3.70159. Epub 2025 Jun 4.

Deutetrabenazine treatment outcomes with doses above U.S. Food and Drug Administration maximum approved doses in Huntington's disease chorea: A dual-site analysis

Dodson K, Livezey S, Denson B, Choi L, DeClercq J, Zuckerman AD, Johnson K.

J Huntingtons Dis. 2025 May;14(2):140-148. doi: 10.1177/18796397251323293. Epub 2025 Mar 23.

Decoding the role of large heat shock proteins in the progression of neuroinflammation-mediated neurodegenerative disorders

Saxena SK, Sharma D, Kumar S, Maurya VK, Ansari S, Malhotra HS, Singh A.

Neuroprotection. 2025 Jan 8;3(1):48-62. doi: 10.1002/nep3.68. eCollection 2025 Mar.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias